Expression profile of receptors for myelin-associated inhibitors of axonal regeneration in the intact and injured mouse central nervous system

Molecular and Cellular Neuroscience

Volumn 34, Issue 4, 2007, Pages 519-538

  Barrette, Benoit ^a   Vallières, Nicolas ^a   Dubé, Marthe ^a   Lacroix, Steve ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

LINGO 1; Myelin associated glycoprotein; Nogo; Nogo 66 receptor; Oligodendrocyte myelin glycoprotein; p75 neurotrophin receptor; Spinal cord injury; TAJ; TROY

Indexed keywords

GLYCOPROTEIN; LINGO 1 PROTEIN; MEMBRANE PROTEIN; MYELIN ASSOCIATED GLYCOPROTEIN; NEUROTROPHIN RECEPTOR; NOGO 66 RECEPTOR; PROTEIN P75; TROY PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN STEM; CENTRAL NERVOUS SYSTEM; CERULOSPINAL TRACT; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NERVE FIBER REGENERATION; NERVE TRACT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PYRAMIDAL TRACT; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RAPHESPINAL TRACT; RETICULOSPINAL TRACT; RUBROSPINAL TRACT; SIGNAL TRANSDUCTION; SPINAL CORD; SPINAL CORD INJURY; VESTIBULOSPINAL TRACT;

ANIMALS; BRAIN; BRAIN INJURIES; EFFERENT PATHWAYS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; MICE, INBRED BALB C; MYELIN PROTEINS; NERVE REGENERATION; NEURONS; SPINAL CORD; SPINAL CORD INJURIES;

EID: 33947581203     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2006.12.004     Document Type: Article

References (78)

1. Barton W.A., Liu B.P., Tzvetkova D., Jeffrey P.D., Fournier A.E., Sah D., Cate R., Strittmatter S.M., and Nikolov D.B. Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins. EMBO J. 22 (2003) 3291-3302
2. Bartsch U., Bandtlow C.E., Schnell L., Bartsch S., Spillmann A.A., Rubin B.P., Hillenbrand R., Montag D., Schwab M.E., and Schachner M. Lack of evidence that myelin-associated glycoprotein is a major inhibitor of axonal regeneration in the CNS. Neuron 15 (1995) 1375-1381
3. Beattie M.S., Harrington A.W., Lee R., Kim J.Y., Boyce S.L., Longo F.M., Bresnahan J.C., Hempstead B.L., and Yoon S.O. ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron 36 (2002) 375-386
4. Benson M.D., Romero M.I., Lush M.E., Lu Q.R., Henkemeyer M., and Parada L.F. Ephrin-B3 is a myelin-based inhibitor of neurite outgrowth. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 10694-10699
5. Buffo A., Zagrebelsky M., Huber A.B., Skerra A., Schwab M.E., Strata P., and Rossi F. Application of neutralizing antibodies against NI-35/250 myelin-associated neurite growth inhibitory proteins to the adult rat cerebellum induces sprouting of uninjured purkinje cell axons. J. Neurosci. 20 (2000) 2275-2286
6. Carim-Todd L., Escarceller M., Estivill X., and Sumoy L. LRRN6A/LERN1 (leucine-rich repeat neuronal protein 1), a novel gene with enriched expression in limbic system and neocortex. Eur. J. Neurosci. 18 (2003) 3167-3182
7. Casha S., Yu W.R., and Fehlings M.G. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 103 (2001) 203-218
8. Chao M.V. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat. Rev., Neurosci. 4 (2003) 299-309
9. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., Christ F., and Schwab M.E. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403 (2000) 434-439
10. NTR as a positive modulator of myelination. Science 298 (2002) 1245-1248
11. David S., and Aguayo A.J. Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. Science 214 (1981) 931-933
12. David S., and Lacroix S. Molecular approaches to spinal cord repair. Annu. Rev. Neurosci. 26 (2003) 411-440
13. Dawbarn D., Allen S.J., and Semenenko F.M. Immunohistochemical localization of beta-nerve growth factor receptors in the forebrain of the rat. Brain Res. 440 (1988) 185-189
14. Domeniconi M., Cao Z., Spencer T., Sivasankaran R., Wang K., Nikulina E., Kimura N., Cai H., Deng K., Gao Y., He Z., and Filbin M. Myelin-associated glycoprotein interacts with the nogo66 receptor to inhibit neurite outgrowth. Neuron 35 (2002) 283-290
15. Dubreuil C.I., Winton M.J., and McKerracher L. Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system. J. Cell Biol. 162 (2003) 233-243
16. Dusart I., Morel M.P., and Sotelo C. Parasagittal compartmentation of adult rat Purkinje cells expressing the low-affinity nerve growth factor receptor: changes of pattern expression after a traumatic lesion. Neuroscience 63 (1994) 351-356
17. GrandPre T., Nakamura F., Vartanian T., and Strittmatter S.M. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403 (2000) 439-444
18. GrandPre T., Li S., and Strittmatter S.M. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 417 (2002) 547-551
19. Hasegawa T., Ohno K., Sano M., Omura T., Omura K., Nagano A., and Sato K. The differential expression patterns of messenger RNAs encoding Nogo-A and Nogo-receptor in the rat central nervous system. Brain Res. Mol. Brain Res. 133 (2005) 119-130
20. Hisaoka T., Morikawa Y., Kitamura T., and Senba E. Expression of a member of tumor necrosis factor receptor superfamily, TROY, in the developing mouse brain. Brain Res. Dev. Brain Res. 143 (2003) 105-109
21. Hunt D., Mason M.R., Campbell G., Coffin R., and Anderson P.N. Nogo receptor mRNA expression in intact and regenerating CNS neurons. Mol. Cell. Neurosci. 20 (2002) 537-552
22. Ji B., Li M., Wu W.T., Yick L.W., Lee X., Shao Z., Wang J., So K.F., McCoy J.M., Blake Pepinsky R., Mi S., and Relton J.K. LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury. Mol. Cell. Neurosci. 33 (2006) 311-320
23. Josephson A., Trifunovski A., Widmer H.R., Widenfalk J., Olson L., and Spenger C. Nogo-receptor gene activity: cellular localization and developmental regulation of mRNA in mice and humans. J. Comp. Neurol. 453 (2002) 292-304
24. Josephson A., Trifunovski A., Scheele C., Widenfalk J., Wahlestedt C., Brene S., Olson L., and Spenger C. Activity-induced and developmental downregulation of the Nogo receptor. Cell Tissue Res. 311 (2003) 333-342
25. Kim J.E., Li S., GrandPre T., Qiu D., and Strittmatter S.M. Axon regeneration in young adult mice lacking Nogo-A/B. Neuron 38 (2003) 187-199
26. Kim J.E., Liu B.P., Park J.H., and Strittmatter S.M. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron 44 (2004) 439-451
27. Kojima T., Morikawa Y., Copeland N.G., Gilbert D.J., Jenkins N.A., Senba E., and Kitamura T. TROY, a newly identified member of the tumor necrosis factor receptor superfamily, exhibits a homology with Edar and is expressed in embryonic skin and hair follicles. J. Biol. Chem. 275 (2000) 20742-20747
28. Koprivica V., Cho K.S., Park J.B., Yiu G., Atwal J., Gore B., Kim J.A., Lin E., Tessier-Lavigne M., Chen D.F., and He Z. EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans. Science 310 (2005) 106-110
29. Lacroix S., and Rivest S. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. J. Neurochem. 70 (1998) 452-466
30. Lacroix S., Feinstein D., and Rivest S. The bacterial endotoxin lipopolysaccharide has the ability to target the brain in upregulating its membrane CD14 receptor within specific cellular populations. Brain Pathol. 8 (1998) 625-640
31. Lacroix S., Chang L., Rose-John S., and Tuszynski M.H. Delivery of Hyper-IL-6 to the injured spinal cord increases neutrophil and macrophage infiltration and inhibits axonal growth. J. Comp. Neurol. 454 (2002) 213-228
32. Lauren J., Airaksinen M.S., Saarma M., and Timmusk T. Two novel mammalian Nogo receptor homologs differentially expressed in the central and peripheral nervous systems. Mol. Cell. Neurosci. 24 (2003) 581-594
33. Li S., and Strittmatter S.M. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J. Neurosci. 23 (2003) 4219-4227
34. Li S., Liu B.P., Budel S., Li M., Ji B., Walus L., Li W., Jirik A., Rabacchi S., Choi E., Worley D., Sah D.W., Pepinsky B., Lee D., Relton J., and Strittmatter S.M. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J. Neurosci. 24 (2004) 10511-10520
35. Li S., Kim J.E., Budel S., Hampton T.G., and Strittmatter S.M. Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury. Mol. Cell. Neurosci. 29 (2005) 26-39
36. Liu B.P., Fournier A., GrandPre T., and Strittmatter S.M. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science 297 (2002) 1190-1193
37. Mandemakers W.J., and Barres B.A. Axon regeneration: it's getting crowded at the gates of TROY. Curr. Biol. 15 (2005) R302-R305
38. Martinez-Murillo R., Caro L., and Nieto-Sampedro M. Lesion-induced expression of low-affinity nerve growth factor receptor-immunoreactive protein in Purkinje cells of the adult rat. Neuroscience 52 (1993) 587-593
39. McKerracher L., David S., Jackson D.L., Kottis V., Dunn R.J., and Braun P.E. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 13 (1994) 805-811
40. Merlio J.P., Ernfors P., Jaber M., and Persson H. Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system. Neuroscience 51 (1992) 513-532
41. Mi S., Lee X., Shao Z., Thill G., Ji B., Relton J., Levesque M., Allaire N., Perrin S., Sands B., Crowell T., Cate R.L., McCoy J.M., and Pepinsky R.B. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat. Neurosci. 7 (2004) 221-228
42. Mi S., Miller R.H., Lee X., Scott M.L., Shulag-Morskaya S., Shao Z., Chang J., Thill G., Levesque M., Zhang M., Hession C., Sah D., Trapp B., He Z., Jung V., McCoy J.M., and Pepinsky R.B. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat. Neurosci. 8 (2005) 745-751
43. Moreau-Fauvarque C., Kumanogoh A., Camand E., Jaillard C., Barbin G., Boquet I., Love C., Jones E.Y., Kikutani H., Lubetzki C., Dusart I., and Chedotal A. The transmembrane semaphorin Sema4D/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion. J. Neurosci. 23 (2003) 9229-9239
44. Mukhopadhyay G., Doherty P., Walsh F.S., Crocker P.R., and Filbin M.T. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 13 (1994) 757-767
45. Park K.I., Jensen F.E., Stieg P.E., Fischer I., and Snyder E.Y. Transplantation of neural stem-like cells engineered to produce NT-3 may enhance neuronal replacement in hypoxia-ischemia CNS injury. Abstr.-Soc. Neurosci. 23 (1997) 346
46. Park J.B., Yiu G., Kaneko S., Wang J., Chang J., He X.L., Garcia K.C., and He Z. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron 45 (2005) 345-351
47. Paxinos G., and Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates (2001), Academic Press
48. Pignot V., Hein A.E., Barske C., Wiessner C., Walmsley A.R., Kaupmann K., Mayeur H., Sommer B., Mir A.K., and Frentzel S. Characterization of two novel proteins, NgRH1 and NgRH2, structurally and biochemically homologous to the Nogo-66 receptor. J. Neurochem. 85 (2003) 717-728
49. Pioro E.P., and Cuello A.C. Distribution of nerve growth factor receptor-like immunoreactivity in the adult rat central nervous system. Effect of colchicine and correlation with the cholinergic system-I. Forebrain. Neuroscience 34 (1990) 57-87
50. Pioro E.P., and Cuello A.C. Distribution of nerve growth factor receptor-like immunoreactivity in the adult rat central nervous system. Effect of colchicine and correlation with the cholinergic system-II. Brainstem, cerebellum and spinal cord. Neuroscience 34 (1990) 89-110
51. Prinjha R., Moore S.E., Vinson M., Blake S., Morrow R., Christie G., Michalovich D., Simmons D.L., and Walsh F.S. Inhibitor of neurite outgrowth in humans. Nature 403 (2000) 383-384
52. Raineteau O., and Schwab M.E. Plasticity of motor systems after incomplete spinal cord injury. Nat. Rev., Neurosci. 2 (2001) 263-273
53. Raineteau O., Fouad K., Noth P., Thallmair M., and Schwab M.E. Functional switch between motor tracts in the presence of the mAb IN-1 in the adult rat. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6929-6934
54. Raisman G. Myelin inhibitors: does NO mean GO?. Nat. Rev., Neurosci. 5 (2004) 157-161
55. Richardson P.M., McGuinness U.M., and Aguayo A.J. Axons from CNS neurons regenerate into PNS grafts. Nature 284 (1980) 264-265
56. Schachner M., and Bartsch U. Multiple functions of the myelin-associated glycoprotein MAG (siglec-4a) in formation and maintenance of myelin. Glia 29 (2000) 154-165
57. Schmued L.C., Albertson C., and Slikker Jr. W. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 751 (1997) 37-46
58. Schwab M.E. Repairing the injured spinal cord. Science 295 (2002) 1029-1031
59. Segal R.A., Pomeroy S.L., and Stiles C.D. Axonal growth and fasciculation linked to differential expression of BDNF and NT3 receptors in developing cerebellar granule cells. J. Neurosci. 15 (1995) 4970-4981
60. Shao Z., Browning J.L., Lee X., Scott M.L., Shulga-Morskaya S., Allaire N., Thill G., Levesque M., Sah D., McCoy J.M., Murray B., Jung V., Pepinsky R.B., and Mi S. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron 45 (2005) 353-359
61. Simonen M., Pedersen V., Weinmann O., Schnell L., Buss A., Ledermann B., Christ F., Sansig G., van der Putten H., and Schwab M.E. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron 38 (2003) 201-211
62. NTR does not promote regeneration of injured spinal cord in mice. J. Neurosci. 24 (2004) 542-546
63. Song X.Y., Zhou F.H., Zhong J.H., Wu L.L., and Zhou X.F. Knockout of p75(NTR) impairs re-myelination of injured sciatic nerve in mice. J. Neurochem. 96 (2006) 833-842
64. Thallmair M., Metz G.A., Z'Graggen W.J., Raineteau O., Kartje G.L., and Schwab M.E. Neurite growth inhibitors restrict plasticity and functional recovery following corticospinal tract lesions. Nat. Neurosci. 1 (1998) 124-131
65. Vallieres L., and Sawchenko P.E. Bone marrow-derived cells that populate the adult mouse brain preserve their hematopoietic identity. J. Neurosci. 23 (2003) 5197-5207
66. Vallieres N., Berard J.L., David S., and Lacroix S. Systemic injections of lipopolysaccharide accelerates myelin phagocytosis during Wallerian degeneration in the injured mouse spinal cord. Glia 53 (2006) 103-113
67. Venkatesh K., Chivatakarn O., Lee H., Joshi P.S., Kantor D.B., Newman B.A., Mage R., Rader C., and Giger R.J. The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein. J. Neurosci. 25 (2005) 808-822
68. Wang K.C., Kim J.A., Sivasankaran R., Segal R., and He Z. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 420 (2002) 74-78
69. Wang K.C., Koprivica V., Kim J.A., Sivasankaran R., Guo Y., Neve R.L., and He Z. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417 (2002) 941-944
70. Wang X., Chun S.J., Treloar H., Vartanian T., Greer C.A., and Strittmatter S.M. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J. Neurosci. 22 (2002) 5505-5515
71. Weidner N., Ner A., Salimi N., and Tuszynski M.H. Spontaneous corticospinal axonal plasticity and functional recovery after adult central nervous system injury. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 3513-3518
72. Whishaw I.Q., Pellis S.M., Gorny B., Kolb B., and Tetzlaff W. Proximal and distal impairments in rat forelimb use in reaching follow unilateral pyramidal tract lesions. Behav. Brain Res. 56 (1993) 59-76
73. Widenfalk J., Lundstromer K., Jubran M., Brene S., and Olson L. Neurotrophic factors and receptors in the immature and adult spinal cord after mechanical injury or kainic acid. J. Neurosci. 21 (2001) 3457-3475
74. Wong S.T., Henley J.R., Kanning K.C., Huang K.H., Bothwell M., and Poo M.M. A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat. Neurosci. 5 (2002) 1302-1308
75. Woolf C.J., and Bloechlinger S. Neuroscience. It takes more than two to Nogo. Science 297 (2002) 1132-1134
76. Yan Q., and Johnson Jr. E.M. An immunohistochemical study of the nerve growth factor receptor in developing rats. J. Neurosci. 8 (1988) 3481-3498
77. Zheng B., Ho C., Li S., Keirstead H., Steward O., and Tessier-Lavigne M. Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron 38 (2003) 213-224
78. Zheng B., Atwal J., Ho C., Case L., He X.L., Garcia K.C., Steward O., and Tessier-Lavigne M. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1205-1210